Overview
Claire Bethune practices in Plymouth, United Kingdom. Ms. Bethune is rated as a Distinguished expert by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Secondary Immunodeficiency (SID), Primary Immunodeficiency (PID), Angioedema, and Hereditary Angioedema.
Her clinical research consists of co-authoring 29 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Secondary Immunodeficiency (SID).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Secondary Immunodeficiency (SID)Ms. Bethune isDistinguished. Learn about Secondary Immunodeficiency (SID).
- Advanced
- Primary Immunodeficiency (PID)Ms. Bethune isAdvanced. Learn about Primary Immunodeficiency (PID).
- Experienced
- Acute Interstitial PneumoniaMs. Bethune isExperienced. Learn about Acute Interstitial Pneumonia.
- AngioedemaMs. Bethune isExperienced. Learn about Angioedema.
- Ataxia-TelangiectasiaMs. Bethune isExperienced. Learn about Ataxia-Telangiectasia.
- Common Variable Immune DeficiencyMs. Bethune isExperienced. Learn about Common Variable Immune Deficiency.
- COVID-19Ms. Bethune isExperienced. Learn about COVID-19.
- Hereditary AngioedemaMs. Bethune isExperienced. Learn about Hereditary Angioedema.